Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Aim. To compare the 24-hour indicators of heart rate variability (HRV), adjusted for age and 24-hour average heart rate (HR24) in women with rheumatoid arthritis (RA) and women of the control group.

Material and methods. Women with RA (n=291) at the age of 20-60 were examined. Women without rheumatic diseases (n=125) were included into control group. The presence of traditional cardiovascular risk factors, the results of 24-hour ECG monitoring were assessed in addition to clinical symptoms, RA activity and severity. Transformation of the initial HRV parameters in their logarithms, and the standardization of the logarithms of age and HR24, the calculation of the exponential of the standardized logarithm were performed to remove the effects of age and heart rate on HRV.

Results. Time and frequency HRV indices, adjusted for age and HP24 (HRVa) in women with RA were lower than these in women of control group. HRVa decline was observed in 14–24% of women with RA. The maximum HRVa decrease was observed among the parameters that reflect an activity of parasympathetic autonomic nervous system (RMSSDn, pNN50n, HFn).

Conclusion. The young and middle age women with RA differ from the women of the control group in significant decrease in the time and spectral HRV indices adjusted for age and HR24.

About the Authors

D. S. Novikova
Research Institute of Rheumatology, Moscow
Russian Federation

T. V. Popkova
Research Institute of Rheumatology, Moscow
Russian Federation

A. N. Gerasimov
I.M. Sechenov First Moscow State Medical University
Russian Federation

A. V. Volkov
Research Institute of Rheumatology, Moscow
Russian Federation

E. I. Nasonov
Research Institute of Rheumatology, Moscow
Russian Federation


1. Popkova TV, Novikova DS, Nasonov EL. Atherosclerosis in rheumatic diseases. In: Nasonov EL, Nasonova VA, eds. Rheumatology: clinical recommendations. Moscow: Geotar-Media; 2010: 678–702. Russian (Попкова Т.В., Новикова Д.С., Насонов Е.Л. Атеросклероз при ревматических заболеваниях. В: Насонов Е.Л., Насонова В.А., редакторы. Ревматология: клинические рекомендации. M.: Геотар-Медиа; 2010: 678–702).

2. Peters M.J., Symmons D.P., McCarey D.W. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis — TASK FORCE ≪Cardiovascular risk management in RA≫. Ann Rheum Dis 2010; 69:325–31.

3. Meune C., Touze E.,Trinquart L., Allanore Y. High risk of clinical cardiovascular events in RA: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010; 103:253–61.

4. Gabriel S.E. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis 2008; 67 (Suppl 3):30–4.

5. Han C., Robinson D.W., Hackett M.V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33:2167–72.

6. Novikova D. S., Popkova T. V., Lisitsyna T. A., Nasonov E. L. Prospects determining heart rate variability in rheumatoid arthritis and systemic lupus erythematosus. Vestnik RAMN 2010; 9:23–34. Russian (Новикова Д. С., Попкова Т. В., Лисицына Т. А., Насонов Е. Л. Перспективы определения вариабельности ритма сердца при ревматоидном артрите и системной красной волчанке. Вестник РАМН 2010; 9:23–34).

7. Goldberg R.J., Larson M., Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996;156:505–10.

8. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93:1043–65.

9. Crawford M.H., Bernstein S.J., Deedwania P.C. et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. JACC 1999; 34(3):912–48.

10. Wolf M.M., Varigos G.A., Hunt D., Sloman J.G. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 15(2):52–3.

11. Kleiger R.E. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256–62.

12. Bigger J.T. Frequency domain measures of heart period variability and mortality rate after myocardial infarction. Circulation 1992; 85:164–71.

13. Tapanainen J.M., Thomsen P.E., Kober L. et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002: 90:347–52.

14. Yi G., Goldman J.H., Keeling P.J. et al. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997: 77(2):108–14.

15. Nolan J., Batin P.D., Andrews N. et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UKHeart). Circulation 1998; 98:1510–6.

16. Schroeder E.B., Chambless L.E., Liao D. et al. Diabetes, glucose, insulin and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes care 2005; 28(3):668–74.

17. Ko S.H., Song K.H., Park S.A. et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med 2008; 25(10):1171–7.

18. Huikuri H., Ylitalo A., Pikkujamsa S.M. et al. HR variability in systemic hypertension. Am J Cardiol 1996; 77(12):1073–7.

19. Park S.K., Schwartz J., Weisskopf M. et al. Low-level lead exposure, metabolic syndrome, and heart rate variability: The VA normative aging study. Environ Health Perspect 2006; 114(11):1718–24.

20. Hillebrand S, Gast KB, de Mutsert R. et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013 [Epub ahead of print].

21. Ramaekers D., Ector H., Aubert A.E., Rubens A., Van de Werf F. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J 1998;19:1334–41.

22. Umetani K., Singer D.H., McCraty R., Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. JАСС 1998;31:593–601.

23. Sokolov S.F., Malkina T.A., Alekseeva Yu.M. et al. Indices of heart rate variability in normal adults: correction for age and heart rate. Funktsional'naya Diagnostika 2007; (3):6–16. Russian (Соколов С.Ф., Малкина Т.А., Алексеева Ю.М. и др. Показатели вариабельности ритма сердца в норме у взрослых: коррекция по возрасту и частоте сердечных сокращений. Функциональная Диагностика 2007; (3):6–16).

24. Evrengul H., Dursunoglu D., Cobankara V. et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004; 24(4):198–202.

25. Anichkov D.A., Shostak N.A., Ivanov D.S. Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients. Int J ClinPract 2007; 61:777–83.

26. Anichkov D.A., Platonova A.A.. The clinical significance of heart rate variability (according to the 5- minute and 24-hour ECG recordings) in patients with rheumatoid arthritis. Rational Pharmacother Card 2009; (1):77–82. Russian (Аничков Д.А., Платонова А.А.. Клиническое значение показа- телей вариабельности сердечного ритма (по данным 5-минутных и 24-часовых записей ЭКГ) у больных ревматоидным артритом. РФК 2009; (1):77–82).

27. Janse van Rensburg D.C., Ker J.A., Grant C.C., Fletcher L. Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis 2012; 15 (4): 419–26.

28. Yadav R.K., Gupta R., Deepak K.K. A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. Indian J Med Res 2012; 136(4):593–8.

29. Arnett F.C., Edworthy S.M., Bloch D.A. The ARA 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315–24.

30. Gerasimov A.N. Medical statistics. Moscow: MIA; 2007. Russian (Герасимов А.Н. Медицинская ста- тистика. М.: МИА; 2007).

31. Crowson C.S., Gabriel S.E. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011;70(5):719–21.

32. Full L.E., Ruisanchez C., Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2009; 11(2), 217.

33. Leuven S.I., Franssen R., Kastelein J.J. et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008;47:3–7.

34. Montecucco F. and Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology2009;48:11–22.

35. Libby P., Ridker P.M, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135–43.

36. Hansson G.K. Inflammation, atherosclerosis and coronary artery disease. New Engl J Med 2005;352:1685–95.

37. Cook S., Togni M., Schaub M. et al. High heart rate: a cardiovascular risk factor? Eur Heart J 2006;27:2387–93.

38. Kaufman C.L., Kaiser D.R., Steinberger J. et al. Relationships between heart rate variability, vascular function, and adiposity in children. ClinAutonRes 2007;17(3):165–71.

39. Schwartz P.J., La Rovere M.T., Mortara A. et. Al. The autonomic nervous system and sudden cardiac death: a rational basis for post-myocardial infarction risk stratification. In Sudden cardiac death. Prevalence, mechanisms, and approaches to diagnosis and management. Ed by Akhtar M., Myerburg R.J., Ruskin J.N. Willams&Wilkins, Philadelphia, 1994:102–23.

40. Zipes D.P. Autonomic innervation of the heart and ventricular arrhythmias. In Sudden cardiac death. Prevalence, mechanisms, and approaches to diagnosis and management. Ed by Akhtar M., Myerburg R.J., Ruskin J.N. Willams&Wilkins, Philadelphia, 1994:341–349.

41. Vlcek M., Rovensky J., Eisenhofer G. et al. Autonomic nervous system function in rheumatoid arthritis. Cell Mol Neurobiol 2012; 32(5):897–901.


For citations:

Novikova D.S., Popkova T.V., Gerasimov A.N., Volkov A.V., Nasonov E.I. COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES. Rational Pharmacotherapy in Cardiology. 2013;9(2):127-132. (In Russ.)

Views: 652

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)